{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:26:56Z","timestamp":1794637616746,"version":"4.9.1"},"reference-count":34,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":225,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p>Persistent B\u2010cell lymphocytosis (PPBL) is a haematological disorder diagnosed primarily in adult female smokers that is characterized by a polyclonal increase in peripheral blood B lymphocytes and a moderate elevation of serum IgM. B lymphocyte\u2010associated cellular abnormalities, such as the occurrence of multi\u2010lobed nuclei, increased <jats:italic>bcl2<\/jats:italic>\/<jats:italic>Ig<\/jats:italic> gene rearrangements and the identification of an extra long\u2010arm chromosome (i3)(q10) in the B\u2010cell population, indicate that PPBL could be part of a multi\u2010step process leading to the emergence of a malignant B lymphoproliferation. However, the resulting impact on cellular functional properties remains to be elucidated. Our goal was to address that aspect via the study of B\u2010cell activity following stimulation through CD40, a key molecule of the tumour\u00a0necrosis factor receptor superfamily involved in B lymphocyte development. In contrast to normal B cells, PPBL B lymphocytes were unable to respond to the proliferative signal delivered <jats:italic>in vitro<\/jats:italic> by CD40, indicating a defect in the CD40 activation pathway. Polymerase chain reaction amplification and sequencing of the receptor as well as FACScan analysis of patient B lymphocytes dismissed the possibility of a defect in either CD40 structure or expression. Moreover, Western blot analysis of tyrosine phosphorylation, an early event in the CD40\u2010signalling cascade, was similar in patients and controls, leading to the conclusion that the defect affecting B lymphocytes in PPBL patients is probably located downstream of that signalling cascade.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02806.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:34:18Z","timestamp":1047364458000},"page":"699-705","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Lack of CD40\u2010dependent B\u2010cell proliferation in B lymphocytes isolated from patients with persistent polyclonal B\u2010cell lymphocytosis"],"prefix":"10.1111","volume":"113","author":[{"given":"Marguerite Massinga","family":"Loemb\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noella","family":"Deslauriers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Darveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Delage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270835"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(00)01605-4"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(94)90062-0"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7679801"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202568"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4233234.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117476"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.852725.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/361541a0"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.11.21.2810"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.158.6.2576","article-title":"Abnormal CD40\u2010mediated activation pathway in B lymphocytes from patients with hyper\u2010IgM syndrome and normal CD40 ligand expression","volume":"158","author":"Durandy A.","year":"1997","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(98)70123-X"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.6.1923"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198207223070407"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1998.0144"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1993.1305"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.4049\/jimmunol.162.6.3298","article-title":"Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein\u2010Barr virus latent membrane protein 1","volume":"162","author":"Henriquez N.V.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.4049\/jimmunol.162.5.2804","article-title":"Requirement for nuclear factor\u2010kappaB activation by a distinct subset of CD40\u2010mediated effector functions in B lymphocytes","volume":"162","author":"Hsing Y.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.4049\/jimmunol.156.7.2345","article-title":"CD40\u2010mediated signaling in B cells. Balancing cell survival, growth, and death","volume":"156","author":"Kehry M.R.","year":"1996","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.6.1700"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.9.1679"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/361539a0"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1353::AID-IMMU1353>3.0.CO;2-2"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.2.337"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830261016"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1996.tb00923.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1421"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/08820139609059292"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.20.14246"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.16.8241"},{"key":"e_1_2_6_32_1","first-page":"4940","article-title":"B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules","volume":"57","author":"Trentin L.","year":"1997","journal-title":"Cancer Research"},{"key":"e_1_2_6_33_1","first-page":"895","article-title":"Lymphocytose polyclonale avec lymphocytes sanguins binucl\u00e9\u00e9s: analyse morphologique, immunologique, cytog\u00e9n\u00e9tique et mol\u00e9culaire de 15 cas","volume":"26","author":"Troussard X.","year":"1997","journal-title":"La Presse Medicale"},{"key":"e_1_2_6_34_1","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood.V90.5.2110","article-title":"Identity between hairy B\u2010cell lymphoproliferative disorder and persistent polyclonal B lymphocytosis?","volume":"90","author":"Troussard X.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1006\/smim.1998.0145"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02806.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02806.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02806.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T15:11:30Z","timestamp":1695827490000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02806.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02806.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02806.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2002-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}